In a cljnical setting of PD, Abdelmoaty et al. by proteomic analysis observed that in PD patients, treatment with sargramostim, a recombinant human granulocyte‐macrophage colony‐stimulating factor, augmented the levels of autophagy‐inducing proteins ATG3, ATG7, and GABARAPL2 within 6 months of therapy with sargramostim [208]. Here, GABARAPL2 is linked to Parkinson disease.